本页面由Tiger Trade Technology Pte. Ltd.提供服务

ORUKA THERAPEUTICS INC

78.19
-2.1600-2.69%
盘后:78.400.2100+0.27%19:55 EDT
成交量:50.07万
成交额:3,953.11万
市值:51.77亿
市盈率:-38.63
高:80.19
开:79.47
低:78.18
收:80.35
52周最高:115.52
52周最低:24.46
股本:6,620.97万
流通股本:5,688.40万
量比:0.51
换手率:0.88%
股息:- -
股息率:- -
每股收益(TTM):-2.0242
每股收益(LYR):-1.8483
净资产收益率:-18.23%
总资产收益率:-12.95%
市净率:4.66
市盈率(LYR):-42.30

数据加载中...

2026/10/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/10/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/09/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/24

重要事件披露

Form 8-K - Current report
2026/08/14

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/08/14

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/12

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/08/10

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/08/10

重要事件披露

Form 8-K - Current report
2026/07/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/07/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/06/05

重要事件披露

Form 8-K - Current report
2026/06/01

重要事件披露

Form 8-K - Current report
2026/05/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities